About WD repeat-containing protein WRAP73
WD repeat-containing protein WRAP73 (WRAP73) is a protein
from Homo sapiens identified by UniProt accession
Q9P2S5, 460 residues long.
MolForge cross-references it against 0 known binders and
15 disease associations.
Target properties
| Protein name | WD repeat-containing protein WRAP73 |
| UniProt accession | Q9P2S5 |
| Gene | WRAP73 |
| Organism | Homo sapiens |
| Length | 460 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (15)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.48
- insomnia · score 0.05
- total blood protein measurement · score 0.05
- PHF-tau measurement · score 0.03
- acute myeloid leukemia · score 0.03
- neuroimaging measurement · score 0.02
- cortical surface area measurement · score 0.02
- diffuse large B-cell lymphoma · score 0.01
- ulcerative colitis · score 0.00
- breast cancer · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9P2S5-F1 | alphafold | PREDICTED | 89.47 | — |
Amino-acid sequence (460 residues)
MNFSEVFKLS SLLCKFSPDG KYLASCVQYR LVVRDVNTLQ ILQLYTCLDQ IQHIEWSADS LFILCAMYKR GLVQVWSLEQ PEWHCKIDEG SAGLVASCWS PDGRHILNTT EFHLRITVWS LCTKSVSYIK YPKACLQGIT FTRDGRYMAL AERRDCKDYV SIFVCSDWQL LRHFDTDTQD LTGIEWAPNG CVLAVWDTCL EYKILLYSLD GRLLSTYSAY EWSLGIKSVA WSPSSQFLAV GSYDGKVRIL NHVTWKMITE FGHPAAINDP KIVVYKEAEK SPQLGLGCLS FPPPRAGAGP LPSSESKYEI ASVPVSLQTL KPVTDRANPK IGIGMLAFSP DSYFLATRND NIPNAVWVWD IQKLRLFAVL EQLSPVRAFQ WDPQQPRLAI CTGGSRLYLW SPAGCMSVQV PGEGDFAVLS LCWHLSGDSM ALLSKDHFCL CFLETEAVVG TACRQLGGHT
Explore WD repeat-containing protein WRAP73 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets